A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
Clinical trial NCT03457012 · COMPLETED
Trial details
- NCT number
- NCT03457012
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-29
- Primary completion
- 2019-12-19
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.